Cargando…

1623. Outcomes of Critically Ill Adults, Hospitalized Patients (Pts) with Pseudomonas aeruginosa (PSA) Hospital- and Ventilator-Associated Pneumonia (HAP/VAP) Who Received an Active Anti-Pseudomonal β-Lactam (ASPB): Does “S” Equal Success in the Presence of Resistance to other ASPB?

BACKGROUND: The most commonly prescribed antibiotics for PSA HAP/VAP are ASPBs: meropenem (MER), piperacillin/tazobactam (TZP),cefepime (FEP) and ceftazidime (CAZ). Similar resistance mechanisms in PSA affect these agents, and it is unclear if you can use a susceptible ASPB when the PSA is resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodise, Thomas, Puzniak, Laura A, Wei, Rong, Tian, Yun, Im, Theresa M, Chen, Lie Hong, Tartof, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777756/ http://dx.doi.org/10.1093/ofid/ofaa439.1803

Ejemplares similares

ASPB welcomes Oxford University Press
por: Blatt, Michael R, et al.
Publicado: (2020)

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?
por: Lodise, Thomas P., et al.
Publicado: (2021)

Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats
por: Tennagels, N., et al.
Publicado: (2013)

Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor
por: Gallagher, Emily Jane, et al.
Publicado: (2013)

Dephosphorylation of the Core Septin, AspB, in a Protein Phosphatase 2A-Dependent Manner Impacts Its Localization and Function in the Fungal Pathogen Aspergillus fumigatus
por: Vargas-Muñiz, José M., et al.
Publicado: (2016)

Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53(R270H/+)WAPCre mouse model
por: ter Braak, Bas, et al.
Publicado: (2015)

De-Escalating Anti-Pseudomonal β-Lactams
por: Catteeuw, J, et al.
Publicado: (2015)

1184. Activity of anti-pseudomonal antibiotics among all Pseudomonas aeruginosa (PSA) at an academic medical health system, including β-lactam, multi-drug (MDR) and extensively drug resistant (XDR) strains
por: Rose, Warren, et al.
Publicado: (2020)

1601. Evaluation of Synergy with β-Lactams Plus Aztreonam Against Pseudomonas aeruginosa (PSA)
por: O’Donnell, J Nicholas, et al.
Publicado: (2019)

Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith?”
por: Chaïbi, Khalil, et al.
Publicado: (2022)

The Lancashire population crisis of 1623
Publicado: (1976)

Johannes Schmiedt (1623–1690)
por: Pekacka-Falkowska, Katarzyna, et al.
Publicado: (2021)

2270. Initial Treatment Selection Among Patients with Recurrent Pseudomonas aeruginosa (PSA) Infections (Infxs): Does Prior PSA Antibiotic Susceptibility Results Effect Subsequent Empiric Treatment Decisions?
por: Puzniak, Laura, et al.
Publicado: (2019)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults
por: Campogiani, Laura, et al.
Publicado: (2019)

1059. Impact of a Syndrome-Based Antimicrobial Stewardship Intervention on Anti-Pseudomonal β-Lactam Use, C. difficile Rates and Cost in an Urban Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2019)

Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials
por: Niederman, Michael S., et al.
Publicado: (2019)

Empiric Usage of “Anti-Pseudomonal” Agents for Hospital-Acquired Urinary Tract Infections
por: Rahat, Ori, et al.
Publicado: (2022)

Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching
por: Baek, Moon Seong, et al.
Publicado: (2023)

Correction to: Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
Publicado: (2023)

Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
por: Heitz, Morgane, et al.
Publicado: (2023)

239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)

663. Incidence of Acute Kidney Injury (AKI) among Adult Hospitalized Patients (pts) with Carbapenem Resistant Gram-Negative Infections (CR-GNIs) Who Received Early Targeted Treatment (TX) with a Newer β-Lactam (BL)-, Colistin (COL)-, or Aminoglycoside (AG)-Containing Regimen
por: Lodise, Thomas, et al.
Publicado: (2022)

468. Assessment of The Proportion of Hospitalized Patients (Pts) with Candidemia (C) and Invasive Candidiasis without Candidemia (IC) Who Received an Echinocandin (EC) and Were Potentially Eligible for an Earlier Hospital Discharge (HD)
por: Lodise, Thomas, et al.
Publicado: (2022)

1883. Acute Kidney Injury in Patients With Pneumonia on Concomitant Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonal β-Lactam Therapy
por: Raux, Brian R, et al.
Publicado: (2018)

Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospital of Kerman, Iran
por: Ahmadipour, Maryam, et al.
Publicado: (2023)

Not all β-lactams are equal regarding neurotoxicity
por: Chaïbi, Khalil, et al.
Publicado: (2016)

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
por: Karolyi, Mario, et al.
Publicado: (2021)

Effect of iron chelation on anti-pseudomonal activity of doxycycline
por: Faure, ME, et al.
Publicado: (2021)

Pseudomonal Diabetic Foot Infections: Vive la Différence?
por: Uçkay, Ilker, et al.
Publicado: (2022)

Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia
por: Puzniak, Laura, et al.
Publicado: (2023)

2414. Real-World Evaluation of Patient Characteristics and Outcomes of Patients Treated With Ceftolozane/Tazobactam Across 253 US Hospitals
por: Puzniak, Laura, et al.
Publicado: (2018)

Effect of Glycyrrhizin on Pseudomonal Skin Infections in Human-Mouse Chimeras
por: Yoshida, Shohei, et al.
Publicado: (2014)

The Changing Humors of Portsmouth. The Medical Biography of an American Town. 1623-1983
por: Louis, Elan Daniel
Publicado: (1988)

The changing humors of Portsmouth. The medical biography of an American town, 1623-1983
por: Duffy, John
Publicado: (1988)

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Application of VAP bundles resulting in low incidence of VAP in ICU
por: Khan, FM, et al.
Publicado: (2011)

Efficacy of anti-pseudomonal antibiotics: Need to reconsider the empirical use of cefepime
por: Kotwal, A., et al.
Publicado: (2014)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

P1623: ROLE OF HLA GENES IN DEVELOPMENT OF HLA-ALLOIMMUNIZATION IN BLOOD RECIPIENTS
por: Butina, E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dq59fjt14fequlri263hk07snh